|
RGMB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.331000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.736600E-01 |
| Normal-vs-Stage2 |
2.917000E-01 |
| Normal-vs-Stage3 |
2.976400E-01 |
| Normal-vs-Stage4 |
2.172000E-01 |
| Stage1-vs-Stage2 |
6.944000E-01 |
| Stage1-vs-Stage3 |
9.798600E-01 |
| Stage1-vs-Stage4 |
7.171800E-01 |
| Stage2-vs-Stage3 |
7.346400E-01 |
| Stage2-vs-Stage4 |
9.258600E-01 |
| Stage3-vs-Stage4 |
7.451200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.766990E-01 |
| Normal-vs-AfricanAmerican |
6.530000E-01 |
| Normal-vs-Asian |
9.348000E-01 |
| Caucasian-vs-AfricanAmerican |
1.440210E-01 |
| Caucasian-vs-Asian |
1.663830E-01 |
| AfricanAmerican-vs-Asian |
6.967000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.890200E-02 |
| Normal-vs-Female |
4.313800E-01 |
| Male-vs-Female |
5.249800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.971040E-01 |
| Normal-vs-Age(41-60Yrs) |
3.774000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.400200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.140010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.934000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.889000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.404000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.697200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.157000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.204200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.352600E-01 |
| Classical-VS-Follicular |
7.966800E-01 |
| Classical-VS-Other |
8.707000E-01 |
| Classical-VS-Normal |
3.467200E-01 |
| Tall-VS-Follicular |
7.135600E-01 |
| Tall-VS-Other |
7.573400E-01 |
| Tall-VS-Normal |
2.355800E-01 |
| Follicular-VS-Other |
8.460200E-01 |
| Follicular-VS-Normal |
3.744400E-01 |
| Other-VS-Normal |
8.449600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.290800E-01 |
| Normal-vs-N1 |
1.156830E-01 |
| N0-vs-N1 |
3.064400E-01 |
|
|
